TerminatedNCT01598896
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
Medication studyAges 18–45United States
Understand this study
Who could participate?
Listed age limits: 18 years to 45 years.
- Listed locations
- BelmontSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 12
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT01598896
- Official title
Show the full official title
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Dronabinol, Clonidine and Placebo.
Who can participate?
Listed age limits: 18 years to 45 years.
Is this study still recruiting?
The registry lists this study as terminated.
